Alcohol dehydrogenase polymorphism and Parkinson's disease

Neuroscience Letters

Volumn 305, Issue 1, 2001, Pages 70-72

  Tan, E K ^a   Nagamitsu, S ^a   Matsuura, T ^a   Khajavi, M ^a   Jankovic, J ^a   Ondo, W ^a   Ashizawa, T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol dehydrogenase; Gene; Huntington's disease; Non amyloid component of plaque; Parkinson's disease; Polymorphism

Indexed keywords

ALCOHOL DEHYDROGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; HUNTINGTON CHOREA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DEHYDROGENASE; ALLELES; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; REFERENCE VALUES; TREMOR;

EID: 0035827476     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01770-0     Document Type: Article

References (19)

1. Buervenich S., Sydow O., Carmine A., Zhang Z.P., Anvret M., Olson L. Alcohol dehydrogenase alleles in Parkinson's disease. Mov. Disord. 5:2000;813-818.
2. Christensen P.M., Gotzsche P.C., Brosen K. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis. Pharmacogenetics. 8:1998;473-479.
3. Deuschl G., Bain P., Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov. Disord. 13:(Suppl. 3):1998;2-23.
4. Farrer M., Gwinn K., Muenter M., De Vrieze F.W., Crook R., Perez-Tur J., Lincoln S., Maraganore D., Adler C., Newman S., MacElwee K., McCarthy P., Miller C., Waters C., Hardy J. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Human Mol. Genetics. 8:1999;81-85.
5. Freely associating. Nat. Genet. 22:1999;1-2.
6. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's disease. Arch. Neurol. 56:1999;33-39.
7. Jankovic J. Essential tremor and other movement disorders. Findley L.J., Koller W. Handbook of Tremor Disorders. 1995;245-262 Marcel Dekker Inc, New York, NY.
8. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
9. Krüger R., Vieira-Saecker A.M., Kuhn W., Berg D., Muller T., Kuhnl N., Fuchs G.A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J.T., Schols L., Riess O. Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype. Ann. Neurol. 45:1999;611-617.
10. Landi M.T., Ceroni M., Martignoni E., Bertazzi P.A., Caporaso N.E., Nappi G. Gene-enviroment interaction in Parkinson's disease: the case of CYP2D6 gene polymorphism. Adv. Neurol. 69:1996;61-72.
11. Markopoulou K., Langston J.W. Candidate genes and Parkinson's disease: where to next? Neurology. 53:1999;1382-1383.
12. McCann S.J., Pond S.M., James K.M., Le Couteur D.G. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J. Neurol. Sci. 153:1997;50-53.
13. Nicholl D.J., Bennett P., Hiller L., Bonifati V., Vanacore N., Fabbrini G., Marconi R., Colosimo C., Lamberti P., Stocchi F., Bonuccelli U., Vieregge P., Ramsden D.B., Meco G., Williams A.C. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology. 53:1999;1415-1421.
14. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
15. Riedl A.G., Watts P.M., Jenner P., Marsden C.D. P450 enzymes and Parkinson's disease: the story so far. Mov. Disord. 13:1998;212-220.
16. Rostami-Hodjegan A., Lannard M.S., Woods H.E., Tucker G.T. Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease. Pharmacogenetics. 8:1998;227-238.
17. Tan E.K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J., Ashizawa T. Polymorphism of NACP-Rep 1 in Parkinson's disease: an etiologic link with essential tremor. Neurology. 54:2000;1195-1198.
18. Tan E.K., Khajavi M., Thornby J.I., Nagamitsu S., Jankovic J., Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 55:2000;533-538.
19. Todd J.A. Interpretation of results from genetic studies of multifactorial diseases. Lancet. 35:1999;S15-S16.